Lakefront Biotherapeutics NV
About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $1.8B
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.8B
- Shares outstanding
- 66.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 18, 2008
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lakefront Biotherapeutics NV.
